Secreted protein acidic and rich in cysteine produced by human melanoma cells modulates polymorphonuclear leukocyte recruitment and antitumor cytotoxic capacity.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Cancer Research

• Publication date

  2005-06-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/0008-5472.CAN-04-1102PMID 15958556
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Matricellular protein SPARC is translocated to the nuclei of immortalized murine lens epithelial cells

  2005cited by this paper
• SPARC and tumor growth: Where the seed meets the soil?

  2004cited by this paper
• Leukocyte, Rather than Tumor-produced SPARC, Determines Stroma and Collagen Type IV Deposition in Mammary Carcinoma

  2003influential reference
• Enhanced growth of tumors in SPARC null mice is associated with changes in the ECM.

  2003cited by this paper
• Platelets may inhibit leucotriene biosynthesis by human neutrophils at the integrin level

  2003cited by this paper
• Bone-related Genes Expressed in Advanced Malignancies Induce Invasion and Metastasis in a Genetically Defined Human Cancer Model*

  2003cited by this paper
• Differential response of primary and metastatic melanomas to neutrophils attracted by IL‐8

  2003cited by this paper
• SPARC inhibits epithelial cell proliferation in part through stimulation of the transforming growth factor-beta-signaling system.

  2003cited by this paper
• Secreted protein acidic and rich in cysteine promotes glioma invasion and delays tumor growth in vivo.

  2002cited by this paper
• Monocyte-Fibronectin Interactions, Via α5β1 Integrin, Induce Expression of CXC Chemokine-Dependent Angiogenic Activity1

  2001cited by this paper
• SPARC, a matricellular protein that functions in cellular differentiation and tissue response to injury.

  2001cited by this paper
• Monocyte-fibronectin interactions, via alpha(5)beta(1) integrin, induce expression of CXC chemokine-dependent angiogenic activity.

  2001cited by this paper
• Inflammatory Cells and Cancer: Think Different!

  2001cited by this paper
• Immune privilege or inflammation? Insights into the Fas ligand enigma

  2001influential reference
• The intriguing role of polymorphonuclear neutrophils in antitumor reactions.

  2001cited by this paper
• The microenvironment of the tumour–host interface

  2001cited by this paper
• Prostaglandins and leukotrienes: advances in eicosanoid biology.

  2001cited by this paper
• A fresh look at tumor immunosurveillance and immunotherapy

  2001cited by this paper
• Inflammatory Cells and Cancer

  2001cited by this paper
• Bleomycin-induced pulmonary injury in mice deficient in SPARC.

  2000cited by this paper
• MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis.

  2000cited by this paper
• MMP-9 Supplied by Bone Marrow – Derived Cells Contributes to Skin Carcinogenesis

  2000cited by this paper
• Collagen accumulation is decreased in SPARC-null mice with bleomycin-induced pulmonary fibrosis.

  1999cited by this paper
• Collagen accumulation is decreased in SPARC-null mice with bleomycin-induced pulmonary fibrosis.

  1999cited by this paper
• Osteonectin promotes prostate cancer cell migration and invasion: a possible mechanism for metastasis to bone.

  1999cited by this paper
• Soluble Fas ligand is chemotactic for human neutrophilic polymorphonuclear leukocytes.

  1999cited by this paper
• SPARC: a potential diagnostic marker of invasive meningiomas.

  1999cited by this paper
• The host environment promotes the constitutive activation of nuclear factor-kappaB and proinflammatory cytokine expression during metastatic tumor progression of murine squamous cell carcinoma.

  1999cited by this paper
• Increased SPARC expression promotes U87 glioblastoma invasion in vitro

  1999cited by this paper
• SPARC Regulates the Expression of Collagen Type I and Transforming Growth Factor-β1 in Mesangial Cells*

  1999cited by this paper
• Activation of SPARC expression in reactive stroma associated with human epithelial ovarian cancer.

  1999cited by this paper
• Regulation of the proinflammatory effects of Fas ligand (CD95L).

  1998cited by this paper
• Caspase 1-independent IL-1β release and inflammation induced by the apoptosis inducer Fas ligand

  1998cited by this paper
• Suppression of SPARC expression by antisense RNA abrogates the tumorigenicity of human melanoma cells

  1997influential reference
• Cells: a laboratory manual

  1997cited by this paper
• Mechanism and biological significance of constitutive expression of MGSA/GRO chemokines in malignant melanoma tumor progression

  1997cited by this paper
• The expression of the secreted protein acidic and rich in cysteine (SPARC) is associated with the neoplastic progression of human melanoma.

  1997cited by this paper
• Human melanoma cells generate leukotrienes B4 and C4 from leukotriene A4

  1997cited by this paper
• Comparative expression of the SPARC and stromelysin-3 genes in mammary tumours

  1996cited by this paper
• Interaction with fibronectin regulates cytokine gene expression in human melanoma cells

  1996cited by this paper
• Melanoma Cell Expression of Fas(Apo-1/CD95) Ligand: Implications for Tumor Immune Escape

  1996cited by this paper
• SPARC, an extracellular matrix protein with tumor-suppressing activity in human ovarian epithelial cells.

  1996cited by this paper
• Protocols for gene transfer in neuroscience : towards gene therapy of neurological disorders

  1996cited by this paper
• Transcriptional activation of the interleukin-8 gene by respiratory syncytial virus infection in alveolar epithelial cells: nuclear translocation of the RelA transcription factor as a mechanism producing airway mucosal inflammation

  1996cited by this paper
• Ultraviolet B irradiation promotes tumorigenic and metastatic properties in primary cutaneous melanoma via induction of interleukin 8.

  1995cited by this paper
• Inhibition of tumor growth by elimination of granulocytes

  1995cited by this paper
• Human melanoma cells generate leukotriene B and C from leukotriene A

  1994cited by this paper
• VLA-4 integrin can mediate CD11/CD18-independent transendothelial migration of human monocytes.

  1993cited by this paper
• Regulation of gene expression by SPARC during angiogenesis in vitro. Changes in fibronectin, thrombospondin-1, and plasminogen activator inhibitor-1.

  1992cited by this paper
• Translocation of HL-60 cell 5-lipoxygenase. Inhibition of A23187- or N-formyl-methionyl-leucyl-phenylalanine-induced translocation by indole and quinoline leukotriene synthesis inhibitors.

  1991cited by this paper
• Macrophage phagocytosis of aging neutrophils in inflammation. Programmed cell death in the neutrophil leads to its recognition by macrophages.

  1989cited by this paper
• Calcium binding domains and calcium-induced conformational transition of SPARC/BM-40/osteonectin, an extracellular glycoprotein expressed in mineralized and nonmineralized tissues.

  1987cited by this paper
• Purification and partial biochemical characterization of a human monocyte-derived, neutrophil-activating peptide that lacks interleukin 1 activity.

  1987cited by this paper
• The immunological aspects of malignant disease.

  1975cited by this paper
• Immunological aspects of malignant disease.

  1967cited by this paper
• A SIMPLE METHOD OF ESTIMATING FIFTY PER CENT ENDPOINTS

  1938cited by this paper
• A simple method of estimating fifty per cent end-points.

  1938cited by this paper

• Identification of Common Cancer Antigens Useful for Specific Immunotherapies to Colorectal Cancer and Liver Metastases

  2025cites this paper
• Identification of 68 HLA-A24 and -A2-restricted cytotoxic T lymphocyte-inducing peptides derived from 10 common cancer-specific antigens frequently expressed in various solid cancers

  2025cites this paper
• SPARC: a potential target for functional nanomaterials and drugs

  2023cites this paper
• The multifaceted role of Matricellular Proteins in health and cancer, as biomarkers and therapeutic targets.

  2022cites this paper
• Bidirectional epithelial–mesenchymal crosstalk provides self-sustaining profibrotic signals in pulmonary fibrosis

  2021cites this paper
• SPARC Overexpression Promotes Liver Cancer Cell Proliferation and Tumor Growth

  2021cites this paper
• Identifying Potential Candidate Hub Genes and Functionally Enriched Pathways in the Immune Responses to Quadrivalent Inactivated Influenza Vaccines in the Elderly Through Co-Expression Network Analysis

  2020cites this paper
• Downregulation of SPARC Expression Decreases Cell Migration and Invasion Involving Epithelial-Mesenchymal Transition through the p-FAK/p-ERK Pathway in Esophageal Squamous Cell Carcinoma

  2020cites this paper
• Cancer Extracellular Matrix Proteins Regulate Tumour Immunity

  2020cites this paper
• Diagnostic and Prognostic Performance of Secreted Protein Acidic and Rich in Cysteine (SPARC) Assay for Detecting Primary and Recurrent Urinary Bladder Cancer

  2019cites this paper
• Extracellular Matrix for Tissue Engineering and Biomaterials

  2019influential citation
• Extracellular Matrix: Immunity and Inflammation

  2018cites this paper
• Metabotropic glutamate receptor-1 regulates inflammation in triple negative breast cancer

  2018cites this paper
• Comparative analysis of DNA methylation patterns of equine sarcoid and healthy skin samples

  2018cites this paper
• Oncolytic Adenovirus-Loaded Menstrual Blood Stem Cells Overcome the Blockade of Viral Activity Exerted by Ovarian Cancer Ascites

  2017cites this paper
• Proteomic profiling identifies markers for inflammation-related tumor–fibroblast interaction

  2017cites this paper
• Prognostic significance of immunohistochemical epithelial-mesenchymal transition markers in skin melanoma patients.

  2016cites this paper
• Predictive Outcomes for HER2-enriched Cancer Using Growth and Metastasis Signatures Driven By SPARC

  2016cites this paper
• Role of SPARC in Cancer; Friend or Foe

  2016cites this paper
• Enhancing the neutrophil-mediated anti-cancer response after oncolytic measles virus therapy in B cell malignancy: dissecting out the mechanism

  2016cites this paper
• Tumour-derived SPARC drives vascular permeability and extravasation through endothelial VCAM1 signalling to promote metastasis

  2015cites this paper
• Polymorphonuclear neutrophils and cancer : the impact of neutrophils on the sensitivity of lymphoma B cells to cancer therapy

  2015cites this paper
• SPARC Controls Melanoma Cell Plasticity through Rac1

  2015cites this paper
• Loss of Sparc in p 53‐null Astrocytes Promotes Macrophage Activation and Phagocytosis Resulting in Decreased Tumor Size and Tumor Cell Survival

  2015cites this paper
• Role of SPARC in Bone Remodeling and Cancer‐Related Bone Metastasis

  2014cites this paper
• SPARC, a matricellular protein that protects cancer from therapy

  2014cites this paper
• Osteonectin (SPARC) Is a Key Regulator of Malignant Pleural Mesothelioma

  2013influential citation
• The Tumor Microenvironment: Characterization, Redox Considerations, and Novel Approaches for Reactive Oxygen Species-Targeted Gene Therapy

  2013cites this paper
• Stromal expression of SPARC in pancreatic adenocarcinoma

  2013cites this paper
• Expression of Secreted Protein Acidic and Rich in Cysteine in the Stroma of a Colorectal Carcinoma is Associated With Patient Prognosis

  2013cites this paper
• Secreted Protein Acidic and Rich in Cysteine (Sparc) in Cancer

  2013cites this paper
• Positive and negative influence of the matrix architecture on antitumor immune surveillance

  2013cites this paper
• MUC5AC protects pancreatic cancer cells from TRAIL-induced death pathways.

  2013cites this paper
• On the dual roles and polarized phenotypes of neutrophils in tumor development and progression.

  2012influential citation
• The Epithelial-Mesenchymal Transition (EMT) Regulatory Factor SLUG (SNAI2) Is a Downstream Target of SPARC and AKT in Promoting Melanoma Cell Invasion

  2012cites this paper
• The roles of secreted protein acidic and rich in cystiene (Sparc) in intestinal inflammation, healing and fibrosis

  2012cites this paper
• The multi-reference contrast method: Facilitating set enrichment analysis

  2012cites this paper
• Matricellular Proteins: A Sticky Affair with Cancers

  2012cites this paper
• Anti-cancer role of SPARC, an inhibitor of adipogenesis.

  2011cites this paper
• SPARC promotes cathepsin B-mediated melanoma invasiveness through a collagen I/α2β1 integrin axis.

  2011cites this paper
• SPARC oppositely regulates inflammation and fibrosis in bleomycin-induced lung damage.

  2011cites this paper
• Protein Profiling of Human Nonpigmented Ciliary Epithelium Cell Secretome: The Differentiation Factors Characterization for Retinal Ganglion Cell line

  2011cites this paper
• Polymorphonuclear neutrophils and cancer: Intense and sustained neutrophilia as a treatment against solid tumors

  2011influential citation
• Elevated plasma levels of SPARC in patients with newly diagnosed type 2 diabetes mellitus.

  2011cites this paper
• The p53/p21Cip1/ Waf1 pathway mediates the effects of SPARC on melanoma cell cycle progression

  2011influential citation
• SPARC and the Tumor Microenvironment

  2011cites this paper
• Dacarbazine promotes stromal remodeling and lymphocyte infiltration in cutaneous melanoma lesions.

  2011cites this paper
• A survey on the distribution of healthy people with different anti-tumour ability

  2010cites this paper
• Rol de la proteína SPARC en los mecanismos de angiogénesis

  2010cites this paper
• Tumour Cell Lines HT-29 and FaDu Produce Proinflammatory Cytokines and Activate Neutrophils In Vitro: Possible Applications for Neutrophil-Based Antitumour Treatment

  2010cites this paper
• Silencing of secreted protein acidic and rich in cysteine inhibits the growth of human melanoma cells with G1 arrest induction

  2010cites this paper
• The function of SPARC in tumor cell biology: SPARC as a modulator of cell-extracellular matrix interaction

  2010cites this paper
• Matricellular proteins: from homeostasis to inflammation, cancer, and metastasis

  2010cites this paper
• El ratón CBA/N xid como modelo animal de inmunodeficiencia. Producción y manejo.

  2010cites this paper
• Pathobiology of the neutrophil-intestinal epithelial cell interaction: role in carcinogenesis.

  2010cites this paper
• Matricellular proteins and inflammatory cells: a task force to promote or defeat cancer?

  2010cites this paper
• dSparc protege a las células de la eliminación por competición celular en Drosophila melanogaster

  2010cites this paper
• Multifunctional Receptor Stabilin-1 in Homeostasis and Disease

  2010cites this paper
• Modulation of matrix remodeling by SPARC in neoplastic progression.

  2010cites this paper
• Multiple Antigen-targeted Immunotherapy With α-Galactosylceramide–loaded and Genetically Engineered Dendritic Cells Derived From Embryonic Stem Cells

  2009cites this paper
• Horizontal gene transfers and cell fusions in microbiology, immunology and oncology (Review).

  2009cites this paper
• Bone marrow-derived cathepsin K cleaves SPARC in bone metastasis.

  2009cites this paper
• Downregulation of SPARC expression inhibits cell migration and invasion in malignant gliomas.

  2009cites this paper
• SPARC: a matricellular regulator of tumorigenesis

  2009cites this paper
• A prototypic matricellular protein in the tumor microenvironment—Where there's SPARC, there's fire

  2008cites this paper
• Eradication of Ovarian Tumor Xenografts by Locoregional Administration of Targeted Immunotherapy

  2008cites this paper
• Adenovirus‐mediated inhibition of SPARC attenuates liver fibrosis in rats

  2008cites this paper
• The role of the matricellular protein SPARC in the dynamic interaction between the tumor and the host

  2008cites this paper
• Olfactory ensheathing cell mediated mechanisms of neurite outgrowth and axon regeneration

  2008cites this paper
• Eradication of OvarianTumor Xenografts by Locoregional Administration ofTargeted Immunotherapy

  2008cites this paper
• Matricellular Proteins Produced by Melanocytes and Melanomas: In Search for Functions

  2008cites this paper
• The role of the matricellular protein SPARC in the dynamic interaction between the tumor and the host

  2008cites this paper
• SPARC in cancer biology: its role in cancer progression and potential for therapy.

  2008cites this paper
• Matricellular proteins at the crossroad of inflammation and cancer.

  2008cites this paper
• Targeting SPARC expression decreases glioma cellular survival and invasion associated with reduced activities of FAK and ILK kinases

  2007cites this paper
• Unraveling mysteries of the multifunctional protein SPARC.

  2007cites this paper
• Proteomic analysis identified N‐cadherin, clusterin, and HSP27 as mediators of SPARC (secreted protein, acidic and rich in cysteines) activity in melanoma cells

  2007cites this paper
• SPARC endogenous level, rather than fibroblast-produced SPARC or stroma reorganization induced by SPARC, is responsible for melanoma cell growth.

  2007cites this paper
• Splenic and immune alterations of the Sparc-null mouse accompany a lack of immune response

  2007cites this paper
• SPARC is a VCAM‐1 counter‐ligand that mediates leukocyte transmigration

  2007cites this paper
• SPARC modulates the proliferation of stromal but not melanoma cells unless endogenous SPARC expression is downregulated

  2007cites this paper
• Overexpression of SPARC protein contrasts with its transcriptional silencing by aberrant hypermethylation of SPARC CpG-rich region in endometrial carcinoma.

  2007cites this paper
• SPARC represses E-cadherin and induces mesenchymal transition during melanoma development.

  2006cites this paper
• Neutrophils Are a Key Component of the Antitumor Efficacy of Topical Chemotherapy with Ingenol-3-Angelate1

  2006cites this paper
• The differential expression of SPARC in esophageal squamous cell carcinoma.

  2006cites this paper
• Review Skin gene therapy for acquired and inherited disorders

  2006cites this paper